148 related articles for article (PubMed ID: 1282201)
1. [Prostatic adenoma: new drugs, new surgical techniques].
Heinzl S
Med Monatsschr Pharm; 1992 Dec; 15(12):362-4. PubMed ID: 1282201
[No Abstract] [Full Text] [Related]
2. Transurethral resection of the prostate: still the gold standard?
Ramsey EW
Can J Surg; 1993 Feb; 36(1):9-10. PubMed ID: 7680274
[No Abstract] [Full Text] [Related]
3. Medical treatment of benign prostatic hyperplasia.
Schmidt JD
West J Med; 1991 Dec; 155(6):633. PubMed ID: 1725942
[No Abstract] [Full Text] [Related]
4. [5-alpha reductase inhibitor in prostatic adenoma?].
Heinzl S
Med Monatsschr Pharm; 1990 Dec; 13(12):382-4. PubMed ID: 1705307
[No Abstract] [Full Text] [Related]
5. Is the prostate pill finally here?
Lange PH
N Engl J Med; 1992 Oct; 327(17):1234-6. PubMed ID: 1383817
[No Abstract] [Full Text] [Related]
6. New options for patients with benign prostatic hyperplasia.
Ellenberger B
CMAJ; 1993 Feb; 148(4):543-7. PubMed ID: 7679313
[No Abstract] [Full Text] [Related]
7. Thoughts on finasteride for benign prostatic hyperplasia.
Anand A
Am Fam Physician; 1993 Sep; 48(4):582, 588. PubMed ID: 7691035
[No Abstract] [Full Text] [Related]
8. Finasteride for benign prostatic hypertrophy.
Med Lett Drugs Ther; 1992 Sep; 34(878):83-4. PubMed ID: 1380630
[No Abstract] [Full Text] [Related]
9. Finasteride for benign prostatic hyperplasia.
Hasinski S; Miller JL; Rose LI
Am Fam Physician; 1992 Nov; 46(5):1511-4. PubMed ID: 1279965
[TBL] [Abstract][Full Text] [Related]
10. Benign prostatic hyperplasia: drug and nondrug therapies.
Bruskewitz RC
Geriatrics; 1992 Dec; 47(12):39-42, 45. PubMed ID: 1280242
[TBL] [Abstract][Full Text] [Related]
11. Finasteride in benign prostatic hyperplasia.
Verhamme KM; Bosch RJ; Sturkenboom MC
N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
[No Abstract] [Full Text] [Related]
12. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].
MMW Fortschr Med; 2002 Oct; 144(44):56. PubMed ID: 12494605
[No Abstract] [Full Text] [Related]
13. What is the best medical treatment for benign prostate hyperplasia?
Evans MF; Frank J
Can Fam Physician; 1997 Jun; 43():1073-4. PubMed ID: 9189295
[No Abstract] [Full Text] [Related]
14. [The tested combination is recommended. Are 5-alpha reductase inhibitors interchangeable?].
MMW Fortschr Med; 2003 Jul; 145(27-28):59. PubMed ID: 14587194
[No Abstract] [Full Text] [Related]
15. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.
Agha AH; Roy JB; Culkin DJ; Lyon K
Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332
[TBL] [Abstract][Full Text] [Related]
16. A current review of medical therapy for benign prostatic hyperplasia.
Brown GA; Sussman DO
J Am Osteopath Assoc; 2004 Feb; 104(2 Suppl 2):S11-6. PubMed ID: 15038398
[TBL] [Abstract][Full Text] [Related]
17. Treatment and pharmacologic management of BPH in the context of common comorbidities.
O'Leary MP
Am J Manag Care; 2006 Apr; 12(5 Suppl):S129-40. PubMed ID: 16613527
[TBL] [Abstract][Full Text] [Related]
18. Effects of long term treatment with finasteride (MK-906), a 5-alpha reductase inhibitor, on circulating LH, FSH, prolactin and estradiol.
Matzkin H; Chen J; Lewyshon O; Ayalon D; Braf Z
Horm Metab Res; 1992 Oct; 24(10):498-9. PubMed ID: 1281461
[No Abstract] [Full Text] [Related]
19. [A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia].
Pushkar' DIu; Kosko DV; Loran OB; Kan IaD; Sapozhnikov IM; Tevlin KP
Urol Nefrol (Mosk); 1995; (4):32-5. PubMed ID: 7571199
[TBL] [Abstract][Full Text] [Related]
20. [5-alpha reductase inhibitors plus alpha blockers. A combination therapy keeps a common disease checked].
MMW Fortschr Med; 2003 Jul; 145(27-28):58-9. PubMed ID: 14587193
[No Abstract] [Full Text] [Related]
[Next] [New Search]
